Deferasirox
Deferasirox
Dispersible tablets, 125 mg, 250 mg, 500 mg
Oral iron chelator primarily indicated for the reduction of chronic iron overload in patients receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.
Instructions for medical use
Up-to-date information on medicinal products is available on the website of the Scientific Centre for Expert Evaluation of Medicinal Products or on the State Register of Medicines portal.
